Osborn Williams & Donohoe’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Osborn Williams & Donohoe’s Portfolio SZYM Stock Details SZYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-25,000	Closed	-$51K	–	231
2016 Q1	$51K	Hold	25,000	–	–	0.01%	219
2015 Q4	$62K	Hold	25,000	–	–	0.01%	216
2015 Q3	$61K	Hold	25,000	–	–	0.01%	207
2015 Q2	$63K	Hold	25,000	–	–	0.01%	216
2015 Q1	$72K	Hold	25,000	–	–	0.01%	229
2014 Q4	$65K	Hold	25,000	–	–	0.01%	226
2014 Q3	$187K	Buy	25,000 +10,000	+67%	+$93.4K	0.04%	220
2014 Q2	$153K	Buy	15,000 +5,000	+50%	+$53.3K	0.03%	222
2014 Q1	$116K	Hold	10,000	–	–	0.03%	215
2013 Q4	$109K	Buy	+10,000	New	+$98.4K	0.02%	223

Osborn Williams & Donohoe's SZYM Position: Q2 2016 in Review

Osborn Williams & Donohoe sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 25,000 shares — an estimated $51K sold.

Osborn Williams & Donohoe first reported a position in SZYM in Q4 2013 and held it in 10 quarters. The position peaked at $187K in Q3 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

Osborn Williams & Donohoe reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
Osborn Williams & Donohoe sold 25,000 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $51K.
Osborn Williams & Donohoe first reported a position in SOLAZYME INC COM STK (DE) in Q4 2013 and held it in 10 quarters.
Osborn Williams & Donohoe's SOLAZYME INC COM STK (DE) position peaked at $187K in Q3 2014.
0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Osborn Williams & Donohoe's 13F filing for Q2 2016, filed 7 Jul 2016.